CHARLES RIV LABS INTL INC shareholders Q2 2022

CHARLES RIV LABS INTL INC's ticker is CRL and the CUSIP is 159864107. A total of 623 filers reported holding CHARLES RIV LABS INTL INC in Q2 2022. The put-call ratio across all filers is 0.77 and the average weighting 0.2%.

CHARLES RIV LABS INTL INC shareholders Q2 2022
Name	Shares	Value	Weighting ↓
Tower House Partners LLP	49,470	$10,585,000	31.02%
Laurus Investment Counsel Inc.	66,485	$14,226,000	6.84%
Prosight Management, LP	27,500	$5,884,000	4.64%
Evolutionary Tree Capital Management, LLC	12,866	$2,753,000	3.00%
Southpoint Capital Advisors LP	400,000	$85,588,000	2.43%
Jackson Square Partners, LLC	435,470	$93,177,000	2.18%
NORRIS PERNE & FRENCH LLP/MI	100,483	$21,500,000	2.07%
LAKEWOOD CAPITAL MANAGEMENT, LP	144,740	$30,970,000	1.92%
J.P. Marvel Investment Advisors, LLC	36,325	$7,772,000	1.87%
Sivik Global Healthcare LLC	15,000	$3,210,000	1.82%
Van Berkom & Associates Inc.	198,946	$42,568,000	1.78%
Legacy Wealth Planning, LLC	5,582	$1,194,000	1.71%
MONTRUSCO BOLTON INVESTMENTS INC.	302,661	$63,887,000	1.70%
Bell Asset Management Ltd	39,642	$8,482,000	1.67%
Curi Wealth Management, LLC	40,416	$8,647,000	1.66%
MADDEN SECURITIES Corp	14,039	$3,004,000	1.65%
IRIDIAN ASSET MANAGEMENT LLC/CT	92,735	$19,843,000	1.62%
INVESTMENT HOUSE LLC	85,225	$18,236,000	1.61%
KINGDON CAPITAL MANAGEMENT, L.L.C.	38,365	$8,209,000	1.39%
AMERICAN CAPITAL MANAGEMENT INC	170,000	$36,375,000	1.36%

About CHARLES RIV LABS INTL INC

Charles River Laboratories International Inc. is a leading provider of research products and services to the pharmaceutical, biotechnology, and medical device industries. The company has a global presence, with operations in North America, Europe, and Asia-Pacific.

Charles River Laboratories International Inc. offers a wide range of services, including drug discovery and development, safety assessment, and clinical support services. The company's expertise in these areas has made it a trusted partner for many of the world's leading pharmaceutical and biotechnology companies.

One of the key strengths of Charles River Laboratories International Inc. is its commitment to innovation. The company invests heavily in research and development, and has a track record of developing new products and services that meet the evolving needs of its customers.

Another important factor in the company's success is its focus on quality. Charles River Laboratories International Inc. has a rigorous quality control system in place, which ensures that its products and services meet the highest standards of safety and efficacy.

Overall, Charles River Laboratories International Inc. is a well-respected and highly regarded company in the pharmaceutical and biotechnology industries. Its commitment to innovation and quality has helped it to maintain a leading position in these markets, and it is well positioned to continue to grow and succeed in the years ahead.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

External links

This page lists CHARLES RIV LABS INTL INC's shareholders in Q2 2022. To view CHARLES RIV LABS INTL INC's shareholder history, click here.